JANUS HENDERSON GROUP PLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$83,177,094
-46.9%
1,099,328
+2.2%
0.06%
-42.6%
Q2 2022$156,709,000
-51.2%
1,075,466
-60.3%
0.11%
-30.3%
Q1 2022$320,892,000
+65.5%
2,706,152
+92.4%
0.16%
+91.4%
Q4 2021$193,840,000
+82.3%
1,406,555
+83.8%
0.08%
+76.1%
Q3 2021$106,313,000
+48.4%
765,375
+3.7%
0.05%
+48.4%
Q2 2021$71,631,000
+45.9%
737,895
+2.8%
0.03%
+40.9%
Q1 2021$49,082,000
-23.8%
718,040
-42.6%
0.02%
-38.9%
Q1 2019$64,420,000
-44.6%
1,251,607
-60.2%
0.04%
-51.4%
Q4 2018$116,256,000
-7.2%
3,143,758
-5.8%
0.07%
+10.4%
Q3 2018$125,301,000
-3.9%
3,336,916
+1.1%
0.07%
-9.5%
Q2 2018$130,388,000
+49.0%
3,299,300
-2.9%
0.07%
+42.3%
Q1 2018$87,484,000
+230.8%
3,396,130
+246.5%
0.05%
+225.0%
Q4 2017$26,443,000
+2.7%
980,109
+42.3%
0.02%
-5.9%
Q3 2017$25,751,000
+59.5%
688,909
+6.7%
0.02%
+54.5%
Q2 2017$16,144,000645,7430.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2023
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders